相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Bjorklund et al.
CLINICAL CANCER RESEARCH (2018)
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells
Veronika Bachanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial
Jeremy Pantin et al.
HAEMATOLOGICA (2017)
Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial
Jeremy Pantin et al.
HAEMATOLOGICA (2017)
Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis
Yvonne Baumer et al.
NATURE COMMUNICATIONS (2017)
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2016)
A novel CXCR4 pathway is required for migration of metastatic breast cancer cells
Jacqueline Freed et al.
CANCER RESEARCH (2015)
Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment
Andrea Ponzetta et al.
CANCER RESEARCH (2015)
Chromothriptic Cure of WHIM Syndrome
David H. McDermott et al.
CELL (2015)
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives
Lukas Pawig et al.
FRONTIERS IN IMMUNOLOGY (2015)
Genetic manipulation of NK cells for cancer immunotherapy: techniques and clinical implications
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors
Concepcion Gomez-Mouton et al.
BLOOD (2015)
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Veronika Bachanova et al.
BLOOD (2014)
Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia
Lieke C. J. van den Berk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Aberrant Expression of CXCR4 Significantly Contributes to Metastasis and Predicts Poor Clinical Outcome in Breast Cancer
P. Yang et al.
CURRENT MOLECULAR MEDICINE (2014)
The CXCR4 and adhesion molecule expression of CD34+hematopoietic cells mobilized by on-demand addition of plerixafor to granulocyte-colony-stimulating factor
Tamara Girbl et al.
TRANSFUSION (2014)
Selective Loss of Chemokine Receptor Expression on Leukocytes after Cell Isolation
Juan C. Nieto et al.
PLOS ONE (2012)
Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip
David Selmeczi et al.
BIOMEDICAL MICRODEVICES (2011)
AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
David H. McDermott et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
HIV-1 Clade B Tat, but Not Clade C Tat, Increases X4 HIV-1 Entry into Resting but Not Activated CD4+ T Cells
Grant R. Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Natural killer cell-mediated lysis of freshly isolated human tumor cells
Mattias Carlsten et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The E3 Ubiquitin Ligase Atrophin Interacting Protein 4 Binds Directly To The Chemokine Receptor CXCR4 Via a Novel WW Domain-mediated Interaction
Deepali Bhandari et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
CXCR4 dimerization and β-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Bernard Lagane et al.
BLOOD (2008)
CCL3 and CXCL 12 regulate trafficking of mouse bone marrow NK cell subsets
Giovanni Bernardini et al.
BLOOD (2008)
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
Evren Alici et al.
BLOOD (2008)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
Tatsuki Sugiyama et al.
IMMUNITY (2006)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
WHIM4 syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
K Balabanian et al.
BLOOD (2005)
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation
J Kahn et al.
BLOOD (2004)
Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice
K Beider et al.
BLOOD (2003)
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
PA Hernandez et al.
NATURE GENETICS (2003)
The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull mice
T Lapidot et al.
LEUKEMIA (2002)
Hematopoietic stem cells are uniquely selective in their migratory response to chemokines
DE Wright et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)